The company raised $57.5 million in February through a public offering and the proceeds will be used to support commercial expansion in the US and EU.

TD Cowen analyst Daniel Brennan maintained a Buy rating on Sera Prognostics (SERA – Research Report) today. The company’s shares closed ...

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by ...

Develon will make its first appearance at this year's edition of Bauma taking place on 7-13 in Munich, Germany. According to ...

OPAP has reported record gross gaming revenue of €2.3 billion in 2024, buoyed by a strong finish to the year from betting and ...

Sera Prognostics Inc ( NASDAQ: SERA) Q4 2024 Earnings Conference Call March 19, 2025 5:00 PM ET Peter DeNardo - IR, CapComm Partners Evguenia Lindgardt - President, CEO & Director Austin Aerts - CFO ...

The company raised $57.5 million in February through a public offering and the proceeds will be used to support commercial expansion in the US and EU.

SALT LAKE CITY - Sera Prognostics Inc. (NASDAQ: SERA ), a company focused on improving maternal and neonatal health, reported fourth quarter 2024 financial results that exceeded analyst expectations ...

Sera Prognostics (SERA) delivered earnings and revenue surprises of -8.70% and 20%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

在该公司发布的最新财报中，公司每股收益为$-0.25，总营收为$24K，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$16.75K，每股收益为$-0.24.

Sera Prognostics (SERA) announced that Jeff Elliott will join its Board of Directors on March 20. Ryan Trimble-after 14 years serving Sera, its ...

Sera Prognostics Inc., The Pregnancy Company® , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that ...